Yeast glucan particles enable intracellular protein delivery in: Drosophila without compromising the immune system

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60461373%3A22330%2F19%3A43919145" target="_blank" >RIV/60461373:22330/19:43919145 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/60461373:22340/19:43919145

Výsledek na webu

<a href="https://doi.org/10.1039/C9BM00539K" target="_blank" >https://doi.org/10.1039/C9BM00539K</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1039/c9bm00539k" target="_blank" >10.1039/c9bm00539k</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Yeast glucan particles enable intracellular protein delivery in: Drosophila without compromising the immune system

Popis výsledku v původním jazyce

Glucan particles derived from yeast have been recently proposed as potential drug delivery carriers. Here, we demonstrate the potential of glucan particles for protein delivery in vivo, using the insect Drosophila melanogaster as a model organism. By employing genetic tools, we demonstrate the capacity of yeast glucan particles to spread efficiently through the Drosophila body, to enter macrophages and to deliver an active transcription factor protein successfully. Moreover, the glucan particles were nontoxic and induced only minimal immune response. The injection of glucan particles did not impair the ability of Drosophila to fight and survive infection by pathogenic bacteria. From this study, Drosophila emerges as an excellent model to test and develop drug delivery systems based on glucan particles, specifically aimed to regulate macrophages. © 2019 The Royal Society of Chemistry.

Název v anglickém jazyce

Yeast glucan particles enable intracellular protein delivery in: Drosophila without compromising the immune system

Popis výsledku anglicky

Glucan particles derived from yeast have been recently proposed as potential drug delivery carriers. Here, we demonstrate the potential of glucan particles for protein delivery in vivo, using the insect Drosophila melanogaster as a model organism. By employing genetic tools, we demonstrate the capacity of yeast glucan particles to spread efficiently through the Drosophila body, to enter macrophages and to deliver an active transcription factor protein successfully. Moreover, the glucan particles were nontoxic and induced only minimal immune response. The injection of glucan particles did not impair the ability of Drosophila to fight and survive infection by pathogenic bacteria. From this study, Drosophila emerges as an excellent model to test and develop drug delivery systems based on glucan particles, specifically aimed to regulate macrophages. © 2019 The Royal Society of Chemistry.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

20401 - Chemical engineering (plants, products)

Projekt

Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2019

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Biomaterials Science

ISSN

2047-4849

e-ISSN

—

Svazek periodika

7

Číslo periodika v rámci svazku

11

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

12

Strana od-do

4708-4719

Kód UT WoS článku

000498818900021

EID výsledku v databázi Scopus

2-s2.0-85073665251